Robert Carpenter
Net worth: 6 M $ as of 30/06/2026
Net worth: 6 M $ as of 30/06/2026
Robert J.
Carpenter is the founder of Olaris, Inc., founded in 2014.
Mr. Carpenter was the founder of GelTex Pharmaceuticals, Inc., founded in 1991, and served as Chairman in 2000.
Mr. Carpenter was the founder of Procept, Inc., founded in 1991, and served as President & Chief Executive Officer in 1998.
Mr. Carpenter was the founder of VacTex, Inc., founded in 1995, and served as President & Chief Executive Officer in 1998.
Mr. Carpenter was the founder of Immuneering Corp., founded in 2008, and served as Chairman from 2008 to 2024.
Mr. Carpenter was the founder of Lysosomal Therapeutics, Inc., founded in 2011, and served as Chairman.
Mr. Carpenter is also the founder of Integrated Genetics, Inc...
Mr. Carpenter was Chairman, Chief Executive Officer & Executive VP at IG Laboratories, Inc. in 1991.
Mr. Carpenter was Chairman at Peptimmune, Inc. from 2002 to 2007.
Mr. Carpenter was Chairman at Hydra Biosciences, Inc. Mr. Carpenter was Director at Cardiac Science, Inc. Mr. Carpenter was Lead Director at Genzyme Corp.
in 2010.
Mr. Carpenter was Director at SynapDx Corp.
Mr. Carpenter was Director at Good Start Genetics, Inc. Mr. Carpenter was Director at ModernaTX, Inc. Mr. Carpenter was President at Boston Medical Investors, Inc. Mr. Carpenter completed graduate studies at Stanford University.
Mr. Carpenter completed undergraduate studies at US Military Academy.
Mr. Carpenter earned an MBA from Harvard Business School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 1,148,839 ( 1.78% ) | 6 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| IMMUNEERING CORPORATION | Founder | 01/01/2008 |
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Director/Board Member | 01/01/2010 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Chairman | 01/08/2007 |
Cardiac Science, Inc.
Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Develops noninvasive automatic external cardiovascular defibrillator devices | Director/Board Member | 02/09/2005 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Founder | 01/12/2000 |
VacTex, Inc. | Chief Executive Officer | 01/04/1998 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 19 |
|---|---|
IG Laboratories, Inc.
IG Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic testing services | Commercial Services |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Cardiac Science, Inc.
Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Develops noninvasive automatic external cardiovascular defibrillator devices | Commercial Services |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Health Technology |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
US Military Academy
US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Boston Medical Investors, Inc.
Boston Medical Investors, Inc. Investment ManagersFinance Boston Medical Investors invests in early-stage health care companies. | Finance |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
SynapDx Corp.
SynapDx Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a laboratory services company which develops a blood-based test for the early detection of autism spectrum disorder | Commercial Services |
Good Start Genetics, Inc.
Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
VacTex, Inc. | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Olaris, Inc.
Olaris, Inc. Hospital/Nursing ManagementHealth Services Provide cancer treatment services | Health Services |
Select your edition
All financial news and data tailored to specific country editions